| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |